Skip to main content
SpringerLink
Log in

Pharmacological Therapy and Prophylaxis

  • Chapter
Age-related macular degeneration

  • 132 Accesses

Abstract

For the majority of patients with age-related macular degeneration (AMD) no therapy is currently available.The disadvantage of existing therapy forms, such as laser coagulation or surgery, lies in the inevitable trauma they cause to surrounding tissues.ln addition, a large proportion of patients do not respond to photodynamic therapy (PDT), and those who do generally still have visual loss after treatment. Most current therapies are also directed against neovascular AMD, while there is no current therapy for dry forms of the disease. Because of this, new therapy forms are desperately needed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Age-Related Eye Disease Study Research Group: The AREDS Study Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, n-carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no.8.Arch Ophthalmol 119:1417–1436

    Google Scholar 

  • Ahuja P, Caffe A.R, Holmgvist I, Soderpalm AK, Singh DP, ShinoharaT,van VeenT (2001) Lens epithelium-derived growth factor ( LEDGF) delays photoreceptor degeneration in ex-plants of rd/rd mouse retina. Neuroreport 12: 2951–2955

    Article  PubMed  CAS  Google Scholar 

  • Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42: 439–446

    PubMed  CAS  Google Scholar 

  • Ben Ezra D, Griffin BW, Maftzir G, Sharif NA, Clark AF (1997) Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis 5ci38: 1954–1962

    Google Scholar 

  • Brouta-Boyé D, Zetter BR (1980) Inhibition of cell motility by interferon. Sci 208: 516–518

    Article  Google Scholar 

  • CiullaTA,Criswell MH, Danis RP, Hill TE (2001) Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model. Arch Ophthalmol 119: 399404

    Google Scholar 

  • Clark AF, Mellon J, Li XY, Ma D, Leher H, Apte R, Alizadeh H, Hegde S, McLenaghan A, Mayhew E, D’Orazio TJ, Niederkorn JY (1999) Inhibition of intraocular tumor growth by topical application of the angiostatic steroid anecortave acetate. Invest Ophthalmol Vis Sci 40: 2158–2162

    PubMed  CAS  Google Scholar 

  • Crum R, Szabo S, Folkman J (1985) A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230: 1375–1378

    Article  PubMed  CAS  Google Scholar 

  • D’Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082–4085

    Article  PubMed  Google Scholar 

  • Engler CB, Sander B, Koefoed P, Larsen M,Vinding R, Lund-Anderson H (1993) Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation. Acta Ophthalmol 71: 27–31

    Article  CAS  Google Scholar 

  • Ezekowitz RAB, Mulliken JB, Folkman J (1992) Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 326: 1456–1463

    Article  PubMed  CAS  Google Scholar 

  • Ferris F, Fine SL, Hyman L (1984) Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 102: 1640–1642

    Article  PubMed  Google Scholar 

  • Fischer D, Pavlidis M,Thanos S (2000) Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture.lnvest Ophthalmol Vis Sci. 41: 3943–3954

    CAS  Google Scholar 

  • Flamm P (1987) Zur Therapie der degenerativen Makulopathie mit Cosaldon A+E. Klin Monatsbl Augenheilkd 190: 59–66

    Article  PubMed  CAS  Google Scholar 

  • Fung WE (1991) Interferon alpha 2a for treatment of age-related macular degeneration. Am J Ophthalmol 112: 349–350

    PubMed  CAS  Google Scholar 

  • Garrett KL, Shen WY, Rakoczy PE (2001) In vivo use of oligonucleotides to inhibit choroidal neovascularization in the eye.J Gene Med 3: 373–383

    Article  PubMed  CAS  Google Scholar 

  • Gasparini G (2001) Metronomic scheduling: the future of chemotherapy? Lancet Oncol 2: 733–740

    Article  PubMed  CAS  Google Scholar 

  • Gillies MC, Chua W, Mitchell P, Billson F, Hunyour A, Penfold P, Simpson J (2002) Photographic and fluorescein angiographic outcomes (abstract from the Intravitreal Triamcinolone Study for Neovascular ARMD). Presented at the Annual ARVO Meeting

    Google Scholar 

  • Hammond BR Jr, Caruso-Avery M (2000) Macular pigment optical density in a Southwestern sample. Invest Ophthalmol Vis Sci 41: 1492–1497

    PubMed  Google Scholar 

  • Heier JS, Sy JP, McCuskey ER (2002) ruhFab V2 (anti-VEGF Antibody) for Treatment of Exudative AMD. Annual Retina Congress Presentation

    Google Scholar 

  • Holekamp MM, Bone KN, Volpert O (2002) Pigment epithelium-derived factor is deficient in the vitrecus of patients with choroidal neovascularisation due to agerelated macular degeneration. Am J Opthtalmol 2002 Aug; 134 (2): 220–227

    Article  CAS  Google Scholar 

  • Holz FG, Miller D (2003) Pharmakologische Therapie der altersabhängigen Makuladegeneration. Ophthalmologe 100: 97–103

    Article  PubMed  CAS  Google Scholar 

  • Holz FG, Schutt F, Kopitz J, Eldred GE, Kruse FE, Volcker HE, Cantz M (1999) Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci. 40: 737–743

    PubMed  CAS  Google Scholar 

  • Holz FG,WolfensbergerTJ, Piguet B,Gross-Jendroska M, Arden GB, Bird AC (1993) Oral zinc-therapy in age-related macular degeneration: a double blind study. Germ J Ophthalmol 2: 391 (Suppl)

    Google Scholar 

  • Holz FG,Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, Chisholm IH, Bird AC (1994) Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology 101: 1522–1528

    Google Scholar 

  • Hruby K (1977) Aussichten und Grenzen der Behandlung seniler Makulopathien mit Phosphatiden. Wien Klin Wochenschr 89: 439–442

    PubMed  CAS  Google Scholar 

  • Hruby K, Wiesflecker J (1983) Trockene senile Makulopathie. Prophylaxe und Therapie in Risikofallen. Klin Monatsbi Augenheilkd 182: 570–575

    Article  CAS  Google Scholar 

  • Jonas JB, Kreissig I, Hugger P,Sauder G, Panda-Jones S, Degenring R (2003) Intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Br J Ophthalmol (in press)

    Google Scholar 

  • Kadonosono K,Yazama F, Itoh N, Sawada H, Ohno S (1999) Expression of matrix metalloproteinase-7 in choroidal neo-vascular membranes in age-related macular degeneration. Am J Ophthalmol 128: 382–384

    Article  PubMed  CAS  Google Scholar 

  • Kaminski MS,Yolton DP,Jordan WT,Yolton RL (1993) Evaluation of dietary antioxidant levels and supplementation with ICAPS-Plus and Ocuvite.J Am Optom Assoc 64: 862–870

    PubMed  CAS  Google Scholar 

  • Karciouglu ZA (1982) Zinc in the eye. Sury Ophthalmol 27: 114

    Article  Google Scholar 

  • Kaven C, Spraul CW, Zavazava N, Lang GK, Lang GE (2001) Thalidomide and prednisolone inhibit growth factor-induced human retinal pigment epithelium cell proliferation in vitro. Ophthalmologica 215: 284–289

    Article  PubMed  CAS  Google Scholar 

  • Karciouglu ZA (1982) Zinc in the eye. Sury Ophthalmol 27: 114

    Article  Google Scholar 

  • Klein R, Klein BE, Linton KL, De Mets DL (1993)The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137: 190–200

    PubMed  CAS  Google Scholar 

  • Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O’Neill CA, Miller JW (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120: 338–46

    Article  PubMed  CAS  Google Scholar 

  • Lambert V, Munaut C, Noel A, Frankenne F, Bajou K, Gerard R, Carmeliet P, Defresne MP, Foidart JM, Rakic JM (2001) Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization. Faseb J 15: 1021–1027

    Article  PubMed  CAS  Google Scholar 

  • Lebuisson DA, Leroy L, Riga, G (1986) Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double-blind drug vs. placebo study. Presse Med 15: 1556–1558

    CAS  Google Scholar 

  • Loughnan MS, Heriot WI, O’Day J (1992) Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha 2a. Aust N Z J Ophthalmol 20: 173–175

    Article  PubMed  CAS  Google Scholar 

  • Maguire MG, Fine SL, Maguire AM, D’Amato RJ, Singerman LJ (2001) AMDATS Research Group: Results of the age-related macular degeneration and thalidomide study ( AMDATS ). Invest Ophthalmol Vis Sci 42: 233

    Google Scholar 

  • McNatt LG, Lane D, Clark AF (1992) Angiostatic activity and metabolism of cortisol in the chorioallantoic membrane ( CAM) of the chick embryo. J Steroid Biochem Mol Biol 42: 687–693

    Article  PubMed  CAS  Google Scholar 

  • McNatt LG, Weimer L,Yanni J, Clark AF (1999) Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization. J Ocul Pharmacol Ther 15: 413–423

    Google Scholar 

  • Melrose MA, Magargal LE, Goldberg RE, Annesley WJ (1987) Subretinal neovascular membranes associated with choroidal nonperfusion and retinal ischemia. Ann Ophthalmol 19: 396–399

    PubMed  CAS  Google Scholar 

  • Miller JW, Shima DT, Tolentino M, Gragoudas ES, Ferrara N, Connolly EJ, Folkman J, D’Amore PA,Adamis AP (1995) Inhibition of VEGF prevents ocular neovascularization in a monkey model. Invest Ophthalmol Vis Sci 36: 401

    Google Scholar 

  • Miller JW, Stinson WG, Folkman J (1993) Regression of experimental iris neovascularization with systemic alpha-interferon.Ophthalmology 100: 9–14

    CAS  Google Scholar 

  • Moon SJ, Mieler WF, Holz ER (2002) Pilot Study of Intravitreal Injektion of Triamcinolone Acetonide in Exudative Age-Related Macular Degenertation. Abstract Presented at the Annual ARVO Meeting

    Google Scholar 

  • Mori K, Gehlbach P, Ando A, McVey D, Wei L, Campochiaro PA (2002a) Regression of ocular neovascularization in response to increased expression of pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 43: 2428–2434

    PubMed  Google Scholar 

  • Mori K, Gehlbach P,Yamamoto S, Duh E, Zack DJ, Li Q, Berns KI, Raisler BJ, Hauswirth WW, Campochiaro PA (2002b) AAVmediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Invest Ophthalmol Vis Sci 43: 1994–2000

    PubMed  Google Scholar 

  • Newsome DA, Swartz M, Leone NC, Elston RC, Miller E (1988) Oral zinc in macular degeneration. Arch Ophthalmol 106: 192–198

    Article  PubMed  CAS  Google Scholar 

  • Oikawa T, Hiragun A, Yoshida Y, Ashino-Fuse H, Tominaga T, Iwaguchi T (1988) Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition. Cancer Lett 43: 85–92

    Article  PubMed  CAS  Google Scholar 

  • Pauleikhoff D, Chen JC, Chisholm IH, Bird AC (1990) Choroidal perfusion abnormality with age-related Bruch’s membrane change. Am J Ophthalmol 109: 211–217

    PubMed  CAS  Google Scholar 

  • Pauleikhoff D,van Kuijk FJ, Bird AC (2001) Makulapigment and altersabhängige Makuladegeneration. Ophthalmologe 98: 511–519

    Google Scholar 

  • Penn JS, Rajaratnam VS, Collier RJ,Clark AF (2001)The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 42: 283–290

    Google Scholar 

  • Pharmacological Therapy for Macular Degeneration Study Group (1997) Interferon alfa-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration: results of a prospective randomized clinical trial. Arch Ophthalmol 115: 865–872

    Google Scholar 

  • Poliner LS,Tornambe PE, Michelson PE, Heitzmann GJ (1993). Interferon alpha-2a for subfoveal neovascularization in age-related macular degeneration. Ophthalmology 100: 1417–1424

    Google Scholar 

  • Proia AD, Hirakata A, McInnes JS, Scroggs MW, Parikh 1 (1993) The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat. Exp Eye Res 57: 693–698

    Article  PubMed  CAS  Google Scholar 

  • Rasmussen H,Chu KW,Campochiaro P,Gehlbach PL, HallerJA., Handa JT,Nguyen QD,Sung JU (2001) Clinical Protocol,An open-label, phase I, single administration, dose-escalation study of ADGVPEDF.11D (ADPEDF) in neovascular age-related macular degeneration ( AMD ). Hum Gene Ther 12: 2029–2032

    Google Scholar 

  • Remulla JF, Gaudio AR, Miller S, Sandberg MA (1995) Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Br J Ophthalmol 79: 558–561

    Article  PubMed  CAS  Google Scholar 

  • Renno RZ, Youssri AI, Michaud N, Gragoudas ES, Miller JW (2002) Expression of pigment epithelium-derived factor in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 43: 1574–1580

    PubMed  Google Scholar 

  • Rieger G (1975) Heilanzeigen fur Jodkurbehandlungen der Augen in Bad Hall. Wien Med Wochenschr 125: 438–439

    PubMed  CAS  Google Scholar 

  • Rieger G (1988) Der Einfluss von kombinierten Jodkurbehandlungen in Bad Hall auf die Farbwahrnehmung von Patienten. Klin Monatsbl Augenheilkd 193: 416–419

    Article  PubMed  CAS  Google Scholar 

  • Rieger G (1992) Veränderungen der Kontrastempfindlichkeit nach kombinierten Jodkurbehandlungen in Bad Hall bei Patienten mit altersbedingter Makulopathie. Ophthalmologica 205: 100–104

    Article  PubMed  CAS  Google Scholar 

  • Robinson MR, Baffi J,Yuan P,Sung C,Byrnes G,CoxTA,Csaky KG (2002) Safety and pharmacokinetics of intravitreal 2methoxyestradiol implants in normal rabbit and pharmacodynamics in a rat model of choroidal neovascularization. Exp Eye Res. 2002. 74: 309–317

    Article  PubMed  CAS  Google Scholar 

  • Roth DB, Spirn M, Yarian DL, Green SN, Leff SR, Friedman ES, Keyser BJ, Wheatly MH (2002) Intravitreal triamcinolone injection for the treatment of occult choroidal neovascularization associated with age-related macular degeneration. Abstract Presented at the Annual ARVO Meeting

    Google Scholar 

  • Scheider A, Neuhauser L (1992) Fluorescence characteristics of drusen during indocyanine-green angiography and their possible correlation with choroidal perfusion. Ger J Ophthalmol 1: 328–334

    PubMed  CAS  Google Scholar 

  • Schütt F, Davies S, Kopitz J, Holz FG, Boulton ME (2000) Photo-damage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci. 41: 2303–2308

    PubMed  Google Scholar 

  • Schütt F, Pauleikhoff D, Holz FG (2002) Vitamine and Spurenelemente bei der altersabhängigen Makuladegeneration. Ophtha Imologe: 99: 301–303

    Article  Google Scholar 

  • Schweigerer L (1988) Basic fibroblast growth factor and its relation to angiogenesis in normal and euplastic tissue. Klin Wochenschr 66: 340–345

    Article  PubMed  CAS  Google Scholar 

  • Sedona JM,Again UA, Sprout RD, Hiller R, Blair N, Burton T, Farber MD,Gragoudas ES, Haller J, Miller DT,Yannuzzi LA,WiIlett W (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group.JAMA 272: 1413–1420

    Google Scholar 

  • Seigel D (2002) AREDS investigators distort findings. Arch Ophthalmol 120: 100–101

    Article  PubMed  Google Scholar 

  • Shalinsky DR, Brekken J, Zou H, McDermott CD, Forsyth P, Edwards D, Margosiak S, Bender S, Truitt G, Wood A, Varki NM,Appelt K (1999) Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials. Ann N Y Acad Sci 878: 236–270

    CAS  Google Scholar 

  • SidkyYA,Borden EC (1987) Inhibition of angiogenesis by interferon: effects on tumor-and lymphocyte-induced vascular responses. Cancer Res 47: 5155–5161

    Google Scholar 

  • Slater JS, Singerman LJ, Russell SR, Hudson HL, D’Amico DJ, Jerdan J, Zillox P, Robertson SM, Anecortave Study Group (2002) Anecortave Acetate Administered as a Posterior Juxtascleral Injection for Subfoveal CNV in Age-Related Macular Degeneration (AMD)-Clinical Results. Annual Retina Congress Presentation

    Google Scholar 

  • Spaide RF, Ho-Spaide WC, Browne R, Armstrong D (1999) Characterization of lipid peroxides in Bruch’s membrane. Retina 19: 141–147

    Article  PubMed  CAS  Google Scholar 

  • Spandau UM, Sauder G,Jonas JB, Hammes HP (2002) Angiostatic effect of crystalline triamcinolone acetonide on ocular neovascularization in vivo. Abstract Presented at the Annual ARVO Meeting

    Google Scholar 

  • Spencer B, Agarwala S, Gentry L, Brandt CR (2001) HSV-1 vector-delivered FGF2 to the retina is neuroprotective but does not preserve functional responses. Mol Ther 3: 746–756

    Article  PubMed  CAS  Google Scholar 

  • Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE (2000) Overexpression of vascular endothelial growth factor ( VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157: 135–144

    Google Scholar 

  • Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A (1998) Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci 39: 2194–2200

    PubMed  CAS  Google Scholar 

  • Stellmach V, Crawford SE, Zhou W, Bouck N (2001) Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor. Proc Natl Acad Sci U S A 98: 2593–2597

    Article  PubMed  CAS  Google Scholar 

  • Stokes CL, Rupnick MA, Williams SK, Lauffenburger DA (1990) Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor. Lab Invest 63: 657–668

    PubMed  CAS  Google Scholar 

  • The Eyetech Study Group (2002a) Anti-VEGF Therapy for Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration: Phase IB Results. Annual ARVO Meeting Presentation

    Google Scholar 

  • The Eyetech Study Group (2002b) Preclinical and phase IA clinical evaluation of an anti-VEGF pegylated aptamer (EYE 001) for the treatment of exudative age-related macular degeneration. Retina 22: 143–152

    Google Scholar 

  • Varga M, Gabriel I, Follmann P (1986) Behandlung der senilen Makulopathie mit Etaretin. Klin Monatsbl Augenheilkd 188: 622–624

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Daniel W. Miller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Stur
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Frank G. Holz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Miller, D.W., Stur, M., Holz, F.G. (2004). Pharmacological Therapy and Prophylaxis. In: Age-related macular degeneration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05199-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05199-3_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-05201-3

  • Online ISBN: 978-3-662-05199-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation